Global Medical REIT Inc. - Common (GMRE)

Historical Holders from Q2 2016 to Q3 2025

Type / Class: Equity / Common
Symbol: GMRE on NYSE
Shares outstanding: 67,214,667
Price per share: $21.17
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 93,254
Holdings value: $877,015
% of all portfolios: 0%
Share change: -43,449,565
Value change: -$301,588,559
Average sells %: -0%
Number of holders: 6
Price from insider filings: $7.38

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Global Medical REIT Inc. - Common (GMRE) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
PRUDENTIAL FINANCIAL INC	5.1%		$26,155,243		3,427,948		PRUDENTIAL FINANCIAL INC	31 Mar 2025

As of 30 Sep 2025, Global Medical REIT Inc. - Common (GMRE) has 6 institutional shareholders filing 13F forms. They hold 93,254 shares of 67,214,667 outstanding shares (0.14%) .

Institutional Holders of Global Medical REIT Inc. - Common (GMRE) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	93,254	$877,015	-$301,588,559	$0		$21.17	6
2025 Q2	44,078,833	$305,915,272	-$7,355,007	$94,248	$0	$6.93	193
2025 Q1	44,918,785	$393,456,951	+$31,186,673	$28,000	$360,500	$8.75	202
2024 Q4	41,584,310	$321,490,394	+$3,617,634	$265,568	$690,940	$7.72	198
2024 Q3	40,605,260	$402,570,518	+$23,882,951	$256,669	$769,016	$9.91	196
2024 Q2	38,096,886	$346,542,704	-$1,821,893	$271,492	$500,308	$9.08	196
2024 Q1	37,308,381	$327,148,789	-$6,833,698	$317,625	$851,375	$8.75	202
2023 Q4	70,775	$785,604	-$7,093			$11.10	2
2023 Q3	35,853,601	$322,028,810	-$3,557,308	$192,855	$1,164,306	$8.97	179
2023 Q2	35,485,647	$324,423,224	-$691,592	$367,026	$668,316	$9.13	181
2023 Q1	35,936,176	$327,798,741	-$18,687,072	$811,868	$954,141	$9.11	190
2022 Q4	38,857,456	$368,874,363	-$26,555,972	$500,544	$1,130,964	$9.48	193
2022 Q3	41,931,150	$358,018,032	-$24,708,740	$796,000	$417,000	$8.52	179
2022 Q2	42,486,943	$476,987,224	-$1,129,634	$797,000	$464,000	$11.23	201
2022 Q1	43,781,650	$714,445,763	+$22,741,977	$710,000	$457,000	$16.32	185
2021 Q4	44,868,201	$796,645,528	+$11,723,712	$850,000	$1,043,000	$17.75	186
2021 Q3	43,655,858	$643,098,236	-$18,081,652	$1,379,000	$1,700,000	$14.70	171
2021 Q2	44,855,219	$662,026,406	+$57,853,856	$1,925,000	$1,948,000	$14.76	166
2021 Q1	41,162,313	$540,256,620	+$114,362,978	$1,631,000	$1,115,000	$13.11	175
2020 Q4	32,376,187	$422,995,011	+$11,496,231	$693,000	$671,000	$13.06	164
2020 Q3	32,076,871	$432,995,072	+$31,305,887	$336,000	$417,000	$13.50	160
2020 Q2	28,813,543	$326,529,588	+$28,834,197	$325,000	$2,496,000	$11.33	145
2020 Q1	26,485,213	$268,026,514	+$12,771,505	$193,000	$1,975,000	$10.12	152
2019 Q4	25,700,381	$340,176,437	+$101,026,190	$1,402,000		$13.23	152
2019 Q3	17,887,370	$202,815,030	+$16,992,670	$1,314,000	$0	$11.40	122
2019 Q2	16,611,205	$173,995,506	-$4,313,069	$1,325,000	$352,000	$10.50	131
2019 Q1	17,030,966	$167,326,491	+$59,306,177	$376,000	$492,000	$9.82	127
2018 Q4	11,018,845	$98,006,020	+$16,416,668	$90,000	$121,000	$8.89	99
2018 Q3	9,101,326	$85,719,822	+$489,980		$108,000	$9.42	89
2018 Q2	9,053,962	$80,225,388	+$7,765,874			$8.86	85
2018 Q1	8,057,567	$55,994,573	-$10,010,903			$6.95	86
2017 Q4	9,676,898	$79,345,883	-$2,403,662			$8.20	90
2017 Q3	8,870,944	$79,662,271	+$7,622,538			$8.98	81
2017 Q2	8,023,942	$71,728,846	+$7,362,593			$8.94	76
2017 Q1	7,201,469	$65,385,962	+$4,182,318			$9.08	63
2016 Q4	7,449,704	$66,459,355	+$4,795,425			$8.92	60
2016 Q3	6,821,430	$66,573,905	+$9,245,933			$9.76	56
2016 Q2	4,931,722	$49,833,470	+$49,833,452			$10.11	31